NRIX R&D to Revenue
Nurix Therapeutics Inc · R&D to Revenue
NRIX R&D to Revenue
Latest reported366.95%period ending
NRIX FY R&D/Revenue (108.18% → 366.95%)
Latest values, visible window
High-resolution chart · PNG
NRIX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 366.9481% | |
| 406.2989% | |
| 245.6882% | |
| 477.6374% | |
| 391.3748% | |
| 373.1425% | |
| 144.7051% | |
| 108.1845% |